Tag: CBT > DEA Scheduling

Cannabis Rescheduling

What to Expect From the DEA’s Cannabis Rescheduling Hearing Transcripts, Final Briefs

A law judge’s recommendation may not come down to whether anti-rescheduling parties proved a Schedule I listing, but whether they disproved the government’s Schedule III evidence.

August 5, 2026

Cannabis Rescheduling

DOJ Head Sidesteps Questions on Schedule III Order, Adult-Use Cannabis

Todd Blanche, Trump’s nominee to be the U.S. attorney general, answered questions for the record about his stances on rescheduling, 280E and enforcement.

July 21, 2026

Cannabis Rescheduling

Cannabis Prohibition Interests Don’t ‘Systemically Align’ With American Public, DOJ Says

The Department of Justice argued that anti-rescheduling groups attempting to stay a Schedule III order have ‘pocketbook interests’ in prohibition.

July 8, 2026

Cannabis Rescheduling

Prohibitionists Punch Back at Cannabis Rescheduling Hearing

Anti-rescheduling participants who oppose the Schedule III proposal attempt to expose flaws in a scientific and medical evaluation and discredit DEA witnesses.

July 1, 2026

Cannabis Rescheduling

DEA Plans to Call Pain Management Doctor, FDA Official to Testify at Cannabis Reschedule Hearing

The Drug Enforcement Administration filed a prehearing statement summarizing its two proposed witnesses’ testimony.

June 26, 2026

Cannabis Rescheduling

Should DEA’s One-Sided Cannabis Rescheduling Hearing Be Reason for Concern?

The government may lack a sufficient administrative record to defend a Schedule III decision in judicial review without any pro-rescheduling participants.

June 24, 2026

Cannabis Rescheduling

DEA Names 7 Anti-Rescheduling Parties for Cannabis Hearing, Zero Pro Parties

Derek C. Julius will be the DEA’s chief administrative law judge to oversee the hearing of a proposed rule to reclassify cannabis as a Schedule III drug.

June 19, 2026

Cannabis Rescheduling

Feds Haven’t Provided ‘Clear Guidance, Feedback’ to Ohio on Cannabis Rescheduling

The state’s Division of Cannabis Control ‘doesn’t have a lot of great answers’ for its dual-licensed operators, the department’s legal counsel says.

June 18, 2026

Cannabis Rescheduling

DEA’s Schedule III Cannabis Registration ‘Coming Soon’ For Cultivators, Manufacturers, Distributors, Labs

The application for non-dispensary businesses to handle Schedule III medical cannabis will be available in the coming weeks.

May 11, 2026

Cannabis Rescheduling

Trulieve Files Applications for DEA Registration of State-Licensed Medical Marijuana Businesses

The company has 200-plus medical cannabis dispensaries it plans to register under the DEA’s expedited process for Schedule III.

April 29, 2026

Cannabis Rescheduling

3 Immediate Implications of Schedule III Leads CBT’s Top Stories in April

Vicente LLP founding partner Brian Vicente broke down the implications, and what else may unfold, in this month’s most-read article.

April 29, 2026

The Last Word

Trulieve CEO ‘Not Concerned’ by DEA’s Middleman Role in Schedule III Order

Kim Rivers dives into the feds’ impending access to her company’s facilities and other treaty obligations, as well as 280E taxes, product development and scientific research.

April 24, 2026